Blog

Jo Taylor: We Need Drug Developments to Overcome Access Inequality in the UK

mollisurgical.com/jo-taylor-2/

Nov 7, 2024, 07:14

Jo Taylor: We Need Drug Developments to Overcome Access Inequality in the UK

Jo Taylor, Founder of After Breast Cancer Diagnosis, posted the following on X:

“We need drug developments to get through the broken National Institute for Health and Care Excellence severity modifier system & available on NHS England because now we have an inequality in the UK where Scotland can access Enhertu for HER2low but England, Wales & Northern Ireland can’t…

Its a crazy situ that patients are in.

Shame on those who stopped this from being approved… I can only see that this will cause big problems for pharma in the future & we METUPUK worry for what will happen…

Awareness & mammograms wont help us – whats the point of a new drug if its not there to help patients survive? Where are the outcomes?”

access inequality cancer cancer care drug development England HER2low Jo Taylor NHS England NICEComms Northern Ireland OncoDaily Oncology Scotland Wales

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity